Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLBII vs TAPB for Analgesia in Kidney Transplantation
NCT02783586Phase 4Completed
- Sponsor
- Medical University of Warsaw
- Start
- Apr 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain, sponsored by Medical University of Warsaw. Primary endpoint: Total postoperative fentanyl usage at 24 hours. Started Apr 2016; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02783586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783586.